Hansa Biopharma to host conference call to provide interim results for January-September 2021 and Business Update
February 14, 2022
141
LUND, Sweden, Oct. 7, 2021 /PRNewswire/ — Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-September 2021 at 8:00 CET on October 21, 2021. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 14:00 CET/8:00am EST. The event will be hosted by Hansa Biopharma’s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English.
Access to content from the Arctic Knowledge Archives is available to subscribers only.
Please sign in to continue, or choose your subscription for unlimited access.
All memberships are considered donations to support this non-profit effort. Institutions and groups should contact us directly for pricing.
Already a subscriber? Log in
Membership
You may select only one level from this group.
Individual Annual
$150.00
Year
Individual Monthly
$15.00
Month
